Ultralife Corporation Files Form 12b-25 Notification of Late Filing
Rhea-AI Summary
Ultralife (NASDAQ: ULBI) filed a Form 12b-25 on Nov 7, 2025, notifying the SEC of a late Form 10-Q for the quarter ended Sept 30, 2025. The company said the late filing follows the conclusion of a transition services agreement with Integer after Ultralife completed its acquisition of Electrochem on Oct 31, 2024, and that Electrochem has moved from Integer's systems to Ultralife systems.
Ultralife stated it needs extra time for finalizing third-quarter results and completing the independent accountant review without unreasonable effort or expense, and it expects to file the Form 10-Q by Nov 17, 2025 in accordance with Rule 12b-25.
Positive
- Completed acquisition of Electrochem on Oct 31, 2024
- Transition services agreement concluded during Q3 2025
- Electrochem systems migrated to Ultralife platforms
- Company expects to file Form 10-Q by Nov 17, 2025
Negative
- Filed Form 12b-25 notifying late Q3 2025 Form 10-Q
- Systems migration required additional time to finalize results
- Independent accountant review delayed by the transition
News Market Reaction 1 Alert
On the day this news was published, ULBI declined 7.56%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended September 30, 2025.
As previously disclosed, on October 31, 2024, Ultralife completed its acquisition of all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) from Integer Holdings Corporation (“Integer”). During the third quarter of 2025, the transition services agreement between Ultralife and Integer under which Integer maintained the books and records of Electrochem on its information systems concluded, and Electrochem transitioned to Ultralife’s systems. In connection with this transition, Ultralife requires additional time to finalize its third quarter results and to provide sufficient time for completion of the review of our third quarter results by our independent accountants without unreasonable effort or expense. Ultralife expects to file its Form 10-Q with the Securities and Exchange Commission by November 17, 2025, in accordance with Rule 12b-25.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.
| Company Contact: | Investor Relations Contact: |
| Ultralife Corporation | Alliance Advisors IR |
| Philip A. Fain | Jody Burfening/Alex Villalta |
| (315) 210-6110 | (212) 838-3777 |
| pfain@ulbi.com | jburfening@allianceadvisors.com |
| avillalta@allianceadvisors.com |
FAQ
Why did Ultralife (ULBI) file a Form 12b-25 on Nov 7, 2025?
When does Ultralife (ULBI) expect to file its Q3 2025 Form 10-Q?
How did the Electrochem acquisition affect Ultralife's Q3 2025 filing timeline for ULBI?
When was Electrochem acquired by Ultralife (ULBI)?
Does Ultralife (ULBI) say the delayed filing will increase accounting expense or restatements?
